Stay updated on Vorinostat and Azacitidine in MDS/AML Clinical Trial
Sign up to get notified when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.

Latest updates to the Vorinostat and Azacitidine in MDS/AML Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference1.0%
- Check10 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 10, 2025.SummaryDifference1.0%
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check60 days agoChange DetectedThe webpage has updated a date from August 2, 2024, to February 10, 2025.SummaryDifference0.9%
- Check67 days agoChange DetectedThe webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check74 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
Stay in the know with updates to Vorinostat and Azacitidine in MDS/AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.